Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Testing Atezolizumab in Patients With Newly Diagnosed, Unresectable, or Metastatic Clear Cell Sarcoma or Chondrosarcoma

    Study Description Go to Brief Summary: This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to...

    Read Article

    Last Notice: Registration for Virtual Dialogue: This Coming Tuesday, September 14 at 7:30PM EST

    Last Notice Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) This Event is Free to...

    Read Article

    Steppin’ for a Cause!

    The Chondrosarcoma Foundation is hosting its first fundraising event to bring awareness to Chondrosarcoma: a rare bone and soft tissue cancer. Where: The comfort of your own neighborhood! When: anytime between October 3rd-9th TO...

    Read Article

    Chondrosarcoma Foundation Hosts it’s first Fund Raising Event

    https://www.eventbrite.com/e/steppin-for-a-cause-tickets-166736518415

    Read Article

    Christian Meyer, M.D.; Ph.D. Bone and Soft Tissue Sarcoma Expert Rounds the Panel for the Virtual Dialogue on September 14

    The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma Survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing...

    Read Article

    Case Study on a Patient with Metastatic Conventional Chondrosarcoma Showing Positive Results

    Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist For more information: Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human...

    Read Article

    Bone Cancer Research Trust publishes 15 year Progress Report on Bone Cancer Research

    Did you know... Research initiated by the Bone Cancer Research Trust discovered that navigation guided surgery improves 5-year chondrosarcoma-specific survival from 53% to 76%! Read about this life-saving breakthrough and many more in our new...

    Read Article

    David Bowles, Ph.D., Author, Psychologist and CS Survivor will address Taking Charge of Your Care on September 14

    Chondrosarcoma CS Foundation, Inc.Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) Join Us for This Very Informative...

    Read Article